Lung Cancer Trial, Not Yet Recruiting NCT07372378 Sponsor: First Affiliated Hospital of Zhejiang University Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT07372378
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are over 50 years of age.
  • People whose overall physical health before surgery is rated as good (classified as ASA status I or II, which means generally healthy or with only mild health conditions — confirm with trial site if unsure which category applies).
  • People whose heart, lungs, and other vital organs are functioning well enough to safely undergo surgery.
  • People who have been assessed as having a moderate-to-high risk of breathing-related complications after surgery, based on a specific scoring tool called the ARISCAT score (a score above 26 — confirm with trial site for details).
  • People who have given their formal written agreement to take part in the trial.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who do not wish to take part, or who have difficulty with memory, thinking, or communicating clearly enough to participate.
  • People whose overall health before surgery is rated as significantly poor (classified as ASA status III or higher, meaning serious ongoing health conditions — confirm with trial site).
  • People who have congestive heart failure, a serious narrowing of the heart's aortic valve, or widespread scarring around the lungs.
  • People who have a severe mental health condition, or who have a known allergy to medications used during anaesthesia.
  • People who have serious problems with how their liver or kidneys are working.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8615267048716

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
First Affiliated Hospital of Zhejiang University
Registry
ClinicalTrials.gov
Start date
20 January 2026
Est. completion
24 January 2029

Primary endpoints

Postoperative Pulmonary Complications (PPCs)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov